The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hereditary Angioedema Market Outlook 2022

Global Hereditary Angioedema Market Outlook 2022

Publishing Date : Nov, 2021

License Type :
 

Report Code : 1634364

No of Pages : 100

Synopsis
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

The global Hereditary Angioedema market was valued at US$ 1656.7 million in 2020 and is expected to reach US$ 2724.1 million by the end of 2027, growing at a CAGR of 7.3% during 2021-2027.

This report focuses on Hereditary Angioedema volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hereditary Angioedema market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Hereditary Angioedema Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist

Segment by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Pharming Group NV
  • Takeda
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.

Scope of the Hereditary Angioedema Market Report

Report Metric

Details

Report Name

Hereditary Angioedema Market

Market size in 2020

US$ 1656.7 Million

The revenue forecast in 2027

US$ 2724.1 Million

Growth Rate

CAGR of 7.3% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Hereditary Angioedema Market Overview
1.1 Product Overview and Scope of Hereditary Angioedema
1.2 Hereditary Angioedema Segment by Type
1.2.1 Global Hereditary Angioedema Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Segment by Distribution Channel
1.3.1 Global Hereditary Angioedema Sales Comparison by Distribution Channel: (2021-2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Market Size Estimates and Forecasts
1.4.1 Global Hereditary Angioedema Revenue 2016-2027
1.4.2 Global Hereditary Angioedema Sales 2016-2027
1.4.3 Hereditary Angioedema Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hereditary Angioedema Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hereditary Angioedema Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hereditary Angioedema Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hereditary Angioedema Manufacturing Sites, Area Served, Product Type
2.5 Hereditary Angioedema Market Competitive Situation and Trends
2.5.1 Hereditary Angioedema Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Players Market Share by Revenue
2.5.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hereditary Angioedema Retrospective Market Scenario by Region
3.1 Global Hereditary Angioedema Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Hereditary Angioedema Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Hereditary Angioedema Market Facts & Figures by Country
3.3.1 North America Hereditary Angioedema Sales by Country
3.3.2 North America Hereditary Angioedema Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hereditary Angioedema Market Facts & Figures by Country
3.4.1 Europe Hereditary Angioedema Sales by Country
3.4.2 Europe Hereditary Angioedema Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hereditary Angioedema Market Facts & Figures by Region
3.5.1 Asia Pacific Hereditary Angioedema Sales by Region
3.5.2 Asia Pacific Hereditary Angioedema Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hereditary Angioedema Market Facts & Figures by Country
3.6.1 Latin America Hereditary Angioedema Sales by Country
3.6.2 Latin America Hereditary Angioedema Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hereditary Angioedema Market Facts & Figures by Country
3.7.1 Middle East and Africa Hereditary Angioedema Sales by Country
3.7.2 Middle East and Africa Hereditary Angioedema Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Hereditary Angioedema Historic Market Analysis by Type
4.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
4.2 Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
4.3 Global Hereditary Angioedema Price by Type (2016-2021)

5 Global Hereditary Angioedema Historic Market Analysis by Distribution Channel
5.1 Global Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
5.2 Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2016-2021)
5.3 Global Hereditary Angioedema Price by Distribution Channel (2016-2021)

6 Key Companies Profiled
6.1 Pharming Group NV
6.1.1 Pharming Group NV Corporation Information
6.1.2 Pharming Group NV Description and Business Overview
6.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pharming Group NV Hereditary Angioedema Product Portfolio
6.1.5 Pharming Group NV Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Hereditary Angioedema Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 CSL Limited
6.3.1 CSL Limited Corporation Information
6.3.2 CSL Limited Description and Business Overview
6.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CSL Limited Hereditary Angioedema Product Portfolio
6.3.5 CSL Limited Recent Developments/Updates
6.4 iBio Inc.
6.4.1 iBio Inc. Corporation Information
6.4.2 iBio Inc. Description and Business Overview
6.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.4.4 iBio Inc. Hereditary Angioedema Product Portfolio
6.4.5 iBio Inc. Recent Developments/Updates
6.5 BioCryst Pharmaceuticals, Inc.
6.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio
6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Ionis Pharmaceuticals, Inc.
6.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio
6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates

7 Hereditary Angioedema Manufacturing Cost Analysis
7.1 Hereditary Angioedema Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hereditary Angioedema
7.4 Hereditary Angioedema Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hereditary Angioedema Distributors List
8.3 Hereditary Angioedema Customers

9 Hereditary Angioedema Market Dynamics
9.1 Hereditary Angioedema Industry Trends
9.2 Hereditary Angioedema Growth Drivers
9.3 Hereditary Angioedema Market Challenges
9.4 Hereditary Angioedema Market Restraints

10 Global Market Forecast
10.1 Hereditary Angioedema Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hereditary Angioedema by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hereditary Angioedema by Type (2022-2027)
10.2 Hereditary Angioedema Market Estimates and Projections by Distribution Channel
10.2.1 Global Forecasted Sales of Hereditary Angioedema by Distribution Channel (2022-2027)
10.2.2 Global Forecasted Revenue of Hereditary Angioedema by Distribution Channel (2022-2027)
10.3 Hereditary Angioedema Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hereditary Angioedema by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hereditary Angioedema by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Hereditary Angioedema Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hereditary Angioedema Sales (MT) Comparison by Distribution Channel (2021-2027)
Table 3. Global Hereditary Angioedema Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hereditary Angioedema Covered in This Study
Table 5. Global Hereditary Angioedema Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Hereditary Angioedema Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Hereditary Angioedema Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hereditary Angioedema Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hereditary Angioedema Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hereditary Angioedema Manufacturing Sites and Area Served
Table 11. Manufacturers Hereditary Angioedema Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hereditary Angioedema by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hereditary Angioedema Sales by Region (2016-2021) & (MT)
Table 16. Global Hereditary Angioedema Sales Market Share by Region (2016-2021)
Table 17. Global Hereditary Angioedema Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 19. North America Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 20. North America Hereditary Angioedema Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 22. Europe Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 23. Europe Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 24. Europe Hereditary Angioedema Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hereditary Angioedema Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Hereditary Angioedema Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hereditary Angioedema Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hereditary Angioedema Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 31. Latin America Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 32. Latin America Hereditary Angioedema Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hereditary Angioedema Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Hereditary Angioedema Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hereditary Angioedema Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hereditary Angioedema Revenue Market Share by Country (2016-2021)
Table 38. Global Hereditary Angioedema Sales (MT) by Type (2016-2021)
Table 39. Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
Table 40. Global Hereditary Angioedema Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hereditary Angioedema Revenue Share by Type (2016-2021)
Table 42. Global Hereditary Angioedema Price (USD/Kg) by Type (2016-2021)
Table 43. Global Hereditary Angioedema Sales (MT) by Distribution Channel (2016-2021)
Table 44. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2016-2021)
Table 45. Global Hereditary Angioedema Revenue (Million US$) by Distribution Channel (2016-2021)
Table 46. Global Hereditary Angioedema Revenue Share by Distribution Channel (2016-2021)
Table 47. Global Hereditary Angioedema Price (USD/Kg) by Distribution Channel (2016-2021)
Table 48. Pharming Group NV Corporation Information
Table 49. Pharming Group NV Description and Business Overview
Table 50. Pharming Group NV Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Pharming Group NV Hereditary Angioedema Product
Table 52. Pharming Group NV Recent Developments/Updates
Table 53. Takeda Corporation Information
Table 54. Takeda Description and Business Overview
Table 55. Takeda Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Takeda Hereditary Angioedema Product
Table 57. Takeda Recent Developments/Updates
Table 58. CSL Limited Corporation Information
Table 59. CSL Limited Description and Business Overview
Table 60. CSL Limited Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. CSL Limited Hereditary Angioedema Product
Table 62. CSL Limited Recent Developments/Updates
Table 63. iBio Inc. Corporation Information
Table 64. iBio Inc. Description and Business Overview
Table 65. iBio Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. iBio Inc. Hereditary Angioedema Product
Table 67. iBio Inc. Recent Developments/Updates
Table 68. BioCryst Pharmaceuticals, Inc. Corporation Information
Table 69. BioCryst Pharmaceuticals, Inc. Description and Business Overview
Table 70. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product
Table 72. BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
Table 73. Ionis Pharmaceuticals, Inc. Corporation Information
Table 74. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 75. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product
Table 77. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Hereditary Angioedema Distributors List
Table 81. Hereditary Angioedema Customers List
Table 82. Hereditary Angioedema Market Trends
Table 83. Hereditary Angioedema Growth Drivers
Table 84. Hereditary Angioedema Market Challenges
Table 85. Hereditary Angioedema Market Restraints
Table 86. Global Hereditary Angioedema Sales Forecast by Type (2022-2027) & (MT)
Table 87. Global Hereditary Angioedema Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Hereditary Angioedema Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Hereditary Angioedema Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Hereditary Angioedema Sales Forecast by Distribution Channel (2022-2027) & (MT)
Table 91. Global Hereditary Angioedema Sales Market Share Forecast by Distribution Channel (2022-2027)
Table 92. Global Hereditary Angioedema Revenue Forecast by Distribution Channel (2022-2027) & (US$ Million)
Table 93. Global Hereditary Angioedema Revenue Market Share Forecast by Distribution Channel (2022-2027)
Table 94. Global Hereditary Angioedema Sales Forecast by Region (2022-2027) & (MT)
Table 95. Global Hereditary Angioedema Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Hereditary Angioedema Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Hereditary Angioedema Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hereditary Angioedema
Figure 2. Global Hereditary Angioedema Market Share by Type in 2020 & 2027
Figure 3. C1 Esterase Inhibitor Product Picture
Figure 4. Kallikrein Inhibitor Product Picture
Figure 5. Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure 6. Global Hereditary Angioedema Market Share by Distribution Channel in 2020 & 2027
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Hereditary Angioedema Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hereditary Angioedema Market Size 2016-2027 (US$ Million)
Figure 12. Global Hereditary Angioedema Sales 2016-2027 (MT)
Figure 13. Global Hereditary Angioedema Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Hereditary Angioedema Sales Share by Manufacturers in 2020
Figure 15. Global Hereditary Angioedema Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Hereditary Angioedema Players: Market Share by Revenue in 2020
Figure 17. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Hereditary Angioedema Sales Market Share by Region (2016-2021)
Figure 19. Global Hereditary Angioedema Sales Market Share by Region in 2020
Figure 20. Global Hereditary Angioedema Revenue Market Share by Region (2016-2021)
Figure 21. Global Hereditary Angioedema Revenue Market Share by Region in 2020
Figure 22. U.S. Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Hereditary Angioedema Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Hereditary Angioedema by Type (2016-2021)
Figure 47. Sales Market Share of Hereditary Angioedema by Distribution Channel (2016-2021)
Figure 48. Sales Market Share of Hereditary Angioedema by Distribution Channel in 2020
Figure 49. Revenue Share of Hereditary Angioedema by Distribution Channel (2016-2021)
Figure 50. Revenue Share of Hereditary Angioedema by Distribution Channel in 2020
Figure 51. Manufacturing Cost Structure of Hereditary Angioedema
Figure 52. Manufacturing Process Analysis of Hereditary Angioedema
Figure 53. Hereditary Angioedema Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’